Table I.

Characteristics of the melanoma patients studieda

PatientsSexAge (year)Site of LNsLNs DissectionTumor StageDisease Interval
SLM2M56Cervical1 N+/4 NIIIb/IIIc2 year
SLM6F55Axillary2 N+/3 NIIIb/IIIcUnknown
SLM8M35Inguino-iliac1 N+/15 NIIIb/IIIc4 year
SLM11F63Inguino-iliac4 N+/12 NIIIc5 year
SLM12F59Inguino-iliac1 N+/8 NIIIb/IIIc4 year
SLM14M81Cervical1 N+/13 NIIIc6 mo
SLM15F64Inguino-iliac5 N+/17 NIIIc15 mo
SLM16M73Axillary2 N+/21 NIIIb/IIIc21 mo
SLM17M64Inguino-iliac12 N+/24 NIIIc6 mo
SLM18M53Inguino-iliac3 N+/12 NIIIc0
SLM19M23Axillary1 N+/11 NIIIb/IIIcUnknown
SLM20F55Inguino-iliac7 N+/17 NIIIc13 year
  • a Twelve stage III melanoma patients with metastatic LNs were included in this study. The anatomical site of surgical LN resection and the results of histopathological examinations are indicated (N, total LNs resected; N+, (metastatic LNs resected). Tumor stages were determined according to the American Joint Commitee for Cancer (41 ). Disease intervals between the removals of the primary cutaneous melanoma and of the metastatic LNs are given. For two patients (SLM6 and SLM19), the primary cutaneous lesion was not evidenced. For another one (SLM18) the primary melanoma and the metastatic LNs were discovered concomitantly.